Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management.
Patnaik MM, Tefferi A. Patnaik MM, et al. Am J Hematol. 2018 Jun;93(6):824-840. doi: 10.1002/ajh.25104. Am J Hematol. 2018. PMID: 29878489 Free PMC article. Review.
DISEASE OVERVIEW: Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell disorder with overlapping features of myelodysplastic syndromes and myeloproliferative neoplasms, with an inherent risk for leukemic transformation (∼15
DISEASE OVERVIEW: Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell disorder with overl
Challenges in Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN).
Smith BN, Savona M, Komrokji RS. Smith BN, et al. Clin Lymphoma Myeloma Leuk. 2019 Jan;19(1):1-8. doi: 10.1016/j.clml.2018.11.019. Epub 2018 Nov 23. Clin Lymphoma Myeloma Leuk. 2019. PMID: 30555034 Review.
The World Health Organization classification coined this group designation in 2008 to include chronic myelomonocytic leukemia, atypical chronic myeloid leukemia, juvenile myelomoncoytic leukemia, refractory anemia with ring siderob …
The World Health Organization classification coined this group designation in 2008 to include chronic myelomonocytic
Feedback